Cargando…
Forces influencing generic drug development in the United States: a narrative review
BACKGROUND: The United States (U.S.) Food and Drug Administration, as protectors of public health, encourages generic drug development and use so that patients can access affordable medications. The FDA, however, has limited mechanisms to encourage generic drug manufacturing. MAIN RESULTS: Generic d...
Autores principales: | Lee, Chia-Ying, Chen, Xiaohan, Romanelli, Robert J., Segal, Jodi B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034442/ https://www.ncbi.nlm.nih.gov/pubmed/27688886 http://dx.doi.org/10.1186/s40545-016-0079-1 |
Ejemplares similares
-
Estimating Generic Drug Use with Electronic Health Records Data from a Health Care Delivery System: Implications for Quality Improvement and Research
por: Nimbal, Vani, et al.
Publicado: (2016) -
Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
por: Sarpatwari, Ameet, et al.
Publicado: (2015) -
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
por: WOUTERS, OLIVIER J., et al.
Publicado: (2017) -
The effect of generic market entry on antibiotic prescriptions in the United States
por: Kållberg, Cecilia, et al.
Publicado: (2021) -
What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice
por: Steinman, Michael A., et al.
Publicado: (2007)